[
THE INVESTOR] Shinhan Investment on July 12 said it expects
LG Life Sciences to post a 99.4 percent increase on-year in its second-quarter operating profit to reach 6.9 billion won (US$ 5.99 million).
The projections are higher than the market consensus of 5.9 billion won.
Shinhan said robust sales of both existing and new products will be the driving factors.
Quarterly sales are consequently expected to rise 15.4 percent to reach 119.6 billion won in line with analysts’ forecasts.
By Kim Ji-hyun (
jemmie@heraldcorp.com)
